Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Clinical Trials

Discovery & Development Clinical Trials

Keeping It Real

| Karen Ooms

Why the industry needs to finally wake up to the real-life benefits of real-world data.

Discovery & Development Drug Discovery

Checkmate for Cachexia?

| Angus Stewart

An interview with Ken Gruber of Endevica Bio on his work producing a treatment for cachexia, a wasting condition common in late-stage cancer.

Business & Regulation Standards & Regulation

The Sacred Texts

| Sue Batchelor

New ICH guideline revisions are imminent. Sue Batchelor of Cmed shares her thoughts on how sponsors and CROs can prepare themselves.

Manufacture Bioprocessing - Upstream & Downstream

A New Focus for Cancer Therapeutics

| Joe Sinclair

Joe Sinclair gives his view on how to be successful with oncolytic virotherapy.

Discovery & Development Drug Discovery

ADCs: Still Room for Improvement!

| Antoine Attinger

Antibody drug conjugates are starting to transform cancer treatments, so let’s maintain the momentum.

Business & Regulation Clinical Trials

Paranoid or Prepared?

| Angus Stewart

Stating an intention to be ready to win in any biowarzone, the US military has commissioned Dynavax to develop a vaccine for the plague.

Discovery & Development Clinical Trials

Please, Sir, May I Have Some Samples?

| Robert Hewitt

Biotech companies need good patient samples, but hospitals are not always obliging...

Discovery & Development Clinical Trials

Taking the Trial to the Patient

| Stephanie Sutton

The way the pharma industry has traditionally handled clinical trials does not make participation easy.

Business & Regulation Clinical Trials

Remembering Henrietta

| Maryam Mahdi

On the 70th anniversary of death Henrietta Lacks, we examine her contributions to science and what they mean for modern research.

Business & Regulation Standards & Regulation

Of Medicine and Machine Learning

| Angus Stewart, Stephanie Sutton

AI is expanding into medicine. Are the world’s regulators ready?


Latest White Papers

Accelerate recruitment with a decentralized clinical trial strategy

| Contributed by Thermo Fisher Scientific

Performance validation of ScatterX78 against NIST reference materials

| Contributed by Malvern Panalytical

Early stage product development using laser diffraction analysis

| Contributed by Malvern Panalytical

All White Papers

Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register